News | Treatment Planning | February 16, 2018

Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning

Cancer center at the University of South Alabama will also use RayStation for CyberKnife System treatment planning when the functionality is added in the future

Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning

February 16, 2018 — The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its treatment planning system for the TomoTherapy System. The center also treats patients using a CyberKnife System and will use RayStation for this in the future.

MCI’s radiation therapy service is equipped with Accuray´s CyberKnife and TomoTherapy System, as well as a 64-slice positron emission tomography/computed tomography (PET/CT) scanner. The center was initially interested in RayStation’s forthcoming support for the CyberKnife System, but saw that the system could meet all of its treatment planning needs into the future, including the TomoTherapy System.

Founded in 2000, MCI provides cancer treatment in three locations — MCI headquarters in Mobile, the MCI Kilborn Clinic in Fairhope and Monroe County Hospital in Monroeville — serving a potential catchment population of more than 4.1 million people.

Weisi Yan, M.D., Ph.D., director of the CyberKnife Program at MCI, said, “We were very impressed by the capabilities and user-friendliness of RayStation. As a leading-edge treatment center, we need the best possible technology in order to deliver outstanding care and maximize efficiency. RayStation will help us to achieve our goals.”

Hal Hopper, manager of MCI’s Department of Radiation Oncology, said, “RayStation is fast and effective in planning treatments for all possible techniques we are likely to offer. It is much less labor-intensive than other systems we have used. With RayStation, the physician can choose the best course of treatment more quickly.”

For more information: www.raysearchlabs.com

 

Related Content

IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
ASTRO 2018 Radiation Therapy Clinical Trials
Feature | ASTRO | October 08, 2018
October 8, 2018 — The American Society for Radiation Oncology (ASTRO) announced the 10 top-rated clinical studies tha
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...
Videos | Treatment Planning | October 05, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri